Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference30 articles.
1. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes;Nielsen;Regul Pept,2004
2. Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial;Bergenstal;Lancet,2010
3. DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes;Blevins;J Clin Endocrinol Metab,2011
4. Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial;Diamant;Lancet,2010
5. Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study;Drucker;Lancet,2008
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. From database to practice: the MBSAQIP in the surgical literature;Surgery for Obesity and Related Diseases;2024-08
2. The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy;Surgery for Obesity and Related Diseases;2024-08
3. Double layer spherical nanoparticles with hyaluronic acid coating to enhance oral delivery of exenatide in T2DM rats;European Journal of Pharmaceutics and Biopharmaceutics;2023-10
4. Interlinking of diabetes mellitus and cancer: An overview;Cell Biochemistry and Function;2023-05-18
5. GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach;Frontiers in Endocrinology;2023-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3